Bankruptcy Court OKs Helicos' IP License Deals with Illumina, Life Tech, Fluidigm, Complete Genomics; Negotiations Ongoing with Roche | GenomeWeb

NEW YORK (GenomeWeb News) – The US bankruptcy court in charge of Helicos BioSciences' Chapter 11 bankruptcy reorganization has approved deals for the company to license its intellectual property to Illumina, Life Technologies, Fluidigm, and Complete Genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.